ATE463503T1 - Verfahren zur verhinderung der bildung von trisulfidderivaten von polypeptiden - Google Patents

Verfahren zur verhinderung der bildung von trisulfidderivaten von polypeptiden

Info

Publication number
ATE463503T1
ATE463503T1 AT05826671T AT05826671T ATE463503T1 AT E463503 T1 ATE463503 T1 AT E463503T1 AT 05826671 T AT05826671 T AT 05826671T AT 05826671 T AT05826671 T AT 05826671T AT E463503 T1 ATE463503 T1 AT E463503T1
Authority
AT
Austria
Prior art keywords
formation
polypeptides
preventing
trisulfide
trisulfide derivatives
Prior art date
Application number
AT05826671T
Other languages
English (en)
Inventor
Peter Becker
Thorkild Christensen
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE463503T1 publication Critical patent/ATE463503T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05826671T 2004-12-29 2005-12-20 Verfahren zur verhinderung der bildung von trisulfidderivaten von polypeptiden ATE463503T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200402022 2004-12-29
PCT/EP2005/056976 WO2006069940A1 (en) 2004-12-29 2005-12-20 Method for preventing formation of trisulfide derivatives of polypeptides

Publications (1)

Publication Number Publication Date
ATE463503T1 true ATE463503T1 (de) 2010-04-15

Family

ID=35986616

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05826671T ATE463503T1 (de) 2004-12-29 2005-12-20 Verfahren zur verhinderung der bildung von trisulfidderivaten von polypeptiden

Country Status (7)

Country Link
US (2) US20090131311A1 (de)
EP (1) EP1833841B1 (de)
JP (1) JP4865728B2 (de)
AT (1) ATE463503T1 (de)
DE (1) DE602005020505D1 (de)
ES (1) ES2344120T3 (de)
WO (1) WO2006069940A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2483289B2 (de) 2009-10-02 2025-03-26 Biogen MA Inc. Verfahren zur vorbeugung und entfernung von trisulphid-bindungen
US9562252B2 (en) 2011-05-13 2017-02-07 Biogen Ma Inc. Methods of preventing and removing trisulfide bonds
KR102463267B1 (ko) * 2014-07-24 2022-11-03 제넨테크, 인크. 적어도 하나의 트리설파이드 결합을 함유하는 단백질에서 티올 모이어티에 제제의 접합 방법
JP7088912B2 (ja) 2016-09-15 2022-06-21 シティ・オブ・ホープ ジチオetp誘導体
WO2018217811A1 (en) * 2017-05-22 2018-11-29 City Of Hope Synthesis of etp derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL97339C (de) 1956-03-02
JPH0720980B2 (ja) 1991-11-26 1995-03-08 株式会社島津製作所 ペプチド合成装置
JPH06220084A (ja) 1993-01-23 1994-08-09 Shimadzu Corp ペプチド合成装置
DK44593D0 (da) 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
US6299776B1 (en) * 1997-12-23 2001-10-09 General Signal Corporation Biochemical oxidation system and process
SE9802454D0 (sv) 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
US20040048315A1 (en) * 2002-08-28 2004-03-11 Pharmacia Corporation Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof

Also Published As

Publication number Publication date
US20100160236A1 (en) 2010-06-24
JP4865728B2 (ja) 2012-02-01
EP1833841A1 (de) 2007-09-19
US8530191B2 (en) 2013-09-10
EP1833841B1 (de) 2010-04-07
WO2006069940A1 (en) 2006-07-06
DE602005020505D1 (de) 2010-05-20
ES2344120T3 (es) 2010-08-18
US20090131311A1 (en) 2009-05-21
JP2008525517A (ja) 2008-07-17

Similar Documents

Publication Publication Date Title
WO2006068978A3 (en) Dipeptidyl peptidase inhibitors
NO20043642L (no) Heterocykiske tripeptider som hepatitt C inhibitorer
DE60217522D1 (de) Verbessertes verfahren zur verschleierung von bitfehlern bei der sprachcodierung
DE60311593D1 (de) System und Verfahren zur Erkennung von Sprach und DTX Moden
DE60232464D1 (de) Verfahren und zusammensetzung zur verbesserung der brenn- oder kraftstoffverbrennung
DE60224275D1 (de) Moleküle und verfahren zur inhibierung der freisetzung von kim-1
DE60300311D1 (de) Symmetrisches Hochfrequenz-Bauelement, Schaltkreis und Verfahren zur Verbesserung der Signalsymmetrie
DE50114564D1 (de) Verfahren zur Regelung von Fluggasturbinen
DE60300191T8 (de) Kommunikationsterminal zur Beschränken der Verwendung von Inhalten
EP1692083A4 (de) Verfahren zur unterdrückung der reaktion von schmelzflüssigen metallen mit feuerfestmaterialien
DE50107254D1 (de) Verfahren zur Instandsetzung von metallischen Bauteilen
DE03713610T1 (de) Neue kristallformen von atorvastatin-hemicalcium und verfahren zu deren herstellung, sowie neue verfahren zur herstellung der formen i, viii und ix von atorvastatin-hemicalcium
DE60321824D1 (de) System und verfahren zur minimierung der modulationsinstabilität
DE60336701D1 (de) Verfahren zum Ersetzen von Turbinenmantelträgerteilen
DE50102346D1 (de) Verfahren zur verbesserung der füllfähigkeit von tabak
DE50208275D1 (de) Verfahren zur Überprüfung der Struktur von Durchgangslöchern eines Bauteils
DE602005020505D1 (de) Verfahren zur verhinderung der bildung von trisulfidderivaten von polypeptiden
DE60209491D1 (de) Zweistufiger abschreckturm zum einsatz im verfahren zur umsetzung von sauerstoffverbindungen
DE60104203D1 (de) Verfahren zur Übertragung von Signalisierungsinformationen über zwei Kanälen
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE60211031D1 (de) Verfahren zur herstellung von hydraulischem zementklinker mit hohem eisengehalt
ATE334748T1 (de) Verfahren zum befüllen von löchern in substraten
DE60232346D1 (de) Verfahren zur weithin ungestützten verbrennung von petroleumkoks
DE60031147D1 (de) Verfahren zum generieren von informationen in zusammenhang mit der molekularstruktur eines biomoleküls
DE50204069D1 (de) Verfahren zur Verflüssigung von CO2 aus der alkoholischen Gärung oder anderen Gasquellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties